Market Cap 647.49M
Revenue (ttm) 100.25M
Net Income (ttm) -73.20M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -73.02%
Debt to Equity Ratio 0.00
Volume 1,328,600
Avg Vol 954,746
Day's Range N/A - N/A
Shares Out 44.56M
Stochastic %K 87%
Beta 3.40
Analysts Strong Sell
Price Target $19.18

Company Profile

Beta Bionics, Inc., a commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of life of insulin-requiring people with diabetes. It offers iLet Bionic Pancreas, an insulin delivery device for the treatment of type 1 diabetes in adults and children six years of age and older. The company is also developing Patch Pump, an insulin pump that is designed to adhere directly to the skin and administer insulin with...

Industry: Medical Devices
Sector: Healthcare
Phone: 949 427 7785
Address:
11 Hughes, Irvine, United States
topstockalerts
topstockalerts Jun. 4 at 10:13 PM
$BBNX the market seems reluctant to let this fade.
0 · Reply
diastud
diastud Jun. 2 at 1:14 AM
$BBNX volume is slowly increasing. This will be 2-3x soon
1 · Reply
ThePatch
ThePatch May. 28 at 7:50 PM
$BBNX has anyone dug into this compares to the Twiist pump?
0 · Reply
1trendingup
1trendingup May. 22 at 2:13 AM
$BBNX https://www.globenewswire.com/news-release/2026/05/21/3299712/0/en/beta-bionics-updates-commercialization-timeline-expectations-for-mint-its-patch-pump-in-development.html No wonder what this is up the last few days…
0 · Reply
deepthinker
deepthinker May. 18 at 3:32 PM
$MODD $BBNX has a patch pump coming in late 2027. I wonder if they could slap the iLet AID on Pivot, and how long that would take to get through the FDA?
1 · Reply
NVDAMillionaire
NVDAMillionaire May. 14 at 2:33 PM
$BBNX Really good write-up that perfectly summarizes BBNX's present situation. So if you want to bring your BBNX knowledge up to date or just discover BBNX, this is required reading. https://everyticker.com/quote/BBNX/analysis/pharmacy-channel-inflection-how-beta-bionics-is-building-a-saas-like-diabetes-franchise-nasdaq-bbnx
0 · Reply
deepthinker
deepthinker May. 13 at 2:18 PM
$BBNX So, they had about $200 million end of Q1. That’s about 8 quarters at current burn. So, they’ll be out of money Q1 of 2028 unless they dilute. The growth is still good, considering they have no patch pump, but I’m not clear what’s going to happen when they burn through their stash.
1 · Reply
MarketBeat
MarketBeat May. 13 at 6:06 AM
https://marketbeat.com/a/8651341/ $BBNX Beta Bionics Touts Pharmacy Push, iLet Momentum and 2027 Mint Patch Pump Plans
0 · Reply
deepthinker
deepthinker May. 10 at 3:18 PM
$BBNX I would be surprised if we don’t get a bid given the crushed stock price here. Easy to consolidate and clean up the SG&A. Toss the iLet in another bag. Too many players in this space.
0 · Reply
deepthinker
deepthinker May. 7 at 1:45 PM
$BBNX My hunch is this company could be in play here. Tandem has supply and IP issues. DEKA is private. Minimed is still owned by Medtronic.
0 · Reply
Latest News on BBNX
Beta Bionics management to meet with Piper Sandler

2026-06-03T20:55:26.000Z - 11 days ago

Beta Bionics management to meet with Piper Sandler


Beta Bionics price target raised to $13 from $11 at BofA

2026-05-22T11:58:04.000Z - 24 days ago

Beta Bionics price target raised to $13 from $11 at BofA


Beta Bionics Transcript: AGM 2026

May 21, 2026, 5:00 PM EDT - 24 days ago

Beta Bionics Transcript: AGM 2026


Beta Bionics price target lowered to $11 from $23 at BofA

2026-05-18T12:00:44.000Z - 4 weeks ago

Beta Bionics price target lowered to $11 from $23 at BofA


Beta Bionics price target lowered to $20 from $22 at Stifel

2026-04-22T11:50:58.000Z - 7 weeks ago

Beta Bionics price target lowered to $20 from $22 at Stifel


Beta Bionics reports Q1 EPS (49c), consensus (45c)

2026-04-21T20:31:34.000Z - 7 weeks ago

Beta Bionics reports Q1 EPS (49c), consensus (45c)


Beta Bionics Earnings Call Transcript: Q1 2026

Apr 21, 2026, 4:30 PM EDT - 7 weeks ago

Beta Bionics Earnings Call Transcript: Q1 2026


Beta Bionics Earnings release: Q1 2026

Apr 21, 2026, 4:30 PM EDT - 7 weeks ago

Beta Bionics Earnings release: Q1 2026


Beta Bionics Slides: Q1 2026

Apr 21, 2026, 4:30 PM EDT - 7 weeks ago

Beta Bionics Slides: Q1 2026


Beta Bionics Quarterly report: Q1 2026

Apr 21, 2026, 4:30 PM EDT - 7 weeks ago

Beta Bionics Quarterly report: Q1 2026


Beta Bionics price target lowered to $18 from $25 at Truist

2026-04-15T12:36:49.000Z - 2 months ago

Beta Bionics price target lowered to $18 from $25 at Truist


Beta Bionics, Inc. Investigated by the Portnoy Law Firm

Apr 14, 2026, 9:00 AM EDT - 2 months ago

Beta Bionics, Inc. Investigated by the Portnoy Law Firm


Beta Bionics Proxy statement: Proxy filing

Apr 10, 2026, 8:00 AM EDT - 2 months ago

Beta Bionics Proxy statement: Proxy filing


Beta Bionics Proxy statement: Proxy filing

Apr 10, 2026, 8:00 AM EDT - 2 months ago

Beta Bionics Proxy statement: Proxy filing


Beta Bionics pullback an ‘overreaction,’ says Lake Street

2026-03-24T12:46:35.000Z - 2 months ago

Beta Bionics pullback an ‘overreaction,’ says Lake Street


Beta Bionics management to meet virtually with Lake Street

2026-03-13T15:00:31.000Z - 3 months ago

Beta Bionics management to meet virtually with Lake Street


Beta Bionics files automatic mixed securities shelf

2026-02-24T22:20:44.000Z - 3 months ago

Beta Bionics files automatic mixed securities shelf


Beta Bionics price target lowered to $14 from $28 at Baird

2026-02-18T12:50:59.000Z - 4 months ago

Beta Bionics price target lowered to $14 from $28 at Baird


Beta Bionics price target lowered to $22 from $25 at Stifel

2026-02-18T11:51:17.000Z - 4 months ago

Beta Bionics price target lowered to $22 from $25 at Stifel


Beta Bionics sees FY26 revenue $130M-$135M, consensus $132.68M

2026-02-17T21:55:25.000Z - 4 months ago

Beta Bionics sees FY26 revenue $130M-$135M, consensus $132.68M


Beta Bionics reports Q4 EPS (30c), consensus (38c)

2026-02-17T21:50:27.000Z - 4 months ago

Beta Bionics reports Q4 EPS (30c), consensus (38c)


Beta Bionics Earnings Call Transcript: Q4 2025

Feb 17, 2026, 4:30 PM EST - 4 months ago

Beta Bionics Earnings Call Transcript: Q4 2025


Beta Bionics Annual report: Q4 2025

Feb 17, 2026, 4:30 PM EST - 4 months ago

Beta Bionics Annual report: Q4 2025


Beta Bionics Earnings release: Q4 2025

Feb 17, 2026, 4:30 PM EST - 4 months ago

Beta Bionics Earnings release: Q4 2025


Beta Bionics Slides: Q4 2025

Feb 17, 2026, 4:30 PM EST - 4 months ago

Beta Bionics Slides: Q4 2025


Beta Bionics initiated with a Buy at UBS

2026-02-09T14:02:04.000Z - 4 months ago

Beta Bionics initiated with a Buy at UBS


Beta Bionics Earnings Call Transcript: Q3 2025

Oct 28, 2025, 4:30 PM EDT - 8 months ago

Beta Bionics Earnings Call Transcript: Q3 2025


Beta Bionics Quarterly report: Q3 2025

Oct 28, 2025, 4:30 PM EDT - 8 months ago

Beta Bionics Quarterly report: Q3 2025


Beta Bionics Earnings release: Q3 2025

Oct 28, 2025, 4:30 PM EDT - 8 months ago

Beta Bionics Earnings release: Q3 2025


Beta Bionics Slides: Q3 2025

Oct 28, 2025, 4:30 PM EDT - 8 months ago

Beta Bionics Slides: Q3 2025


topstockalerts
topstockalerts Jun. 4 at 10:13 PM
$BBNX the market seems reluctant to let this fade.
0 · Reply
diastud
diastud Jun. 2 at 1:14 AM
$BBNX volume is slowly increasing. This will be 2-3x soon
1 · Reply
ThePatch
ThePatch May. 28 at 7:50 PM
$BBNX has anyone dug into this compares to the Twiist pump?
0 · Reply
1trendingup
1trendingup May. 22 at 2:13 AM
$BBNX https://www.globenewswire.com/news-release/2026/05/21/3299712/0/en/beta-bionics-updates-commercialization-timeline-expectations-for-mint-its-patch-pump-in-development.html No wonder what this is up the last few days…
0 · Reply
deepthinker
deepthinker May. 18 at 3:32 PM
$MODD $BBNX has a patch pump coming in late 2027. I wonder if they could slap the iLet AID on Pivot, and how long that would take to get through the FDA?
1 · Reply
NVDAMillionaire
NVDAMillionaire May. 14 at 2:33 PM
$BBNX Really good write-up that perfectly summarizes BBNX's present situation. So if you want to bring your BBNX knowledge up to date or just discover BBNX, this is required reading. https://everyticker.com/quote/BBNX/analysis/pharmacy-channel-inflection-how-beta-bionics-is-building-a-saas-like-diabetes-franchise-nasdaq-bbnx
0 · Reply
deepthinker
deepthinker May. 13 at 2:18 PM
$BBNX So, they had about $200 million end of Q1. That’s about 8 quarters at current burn. So, they’ll be out of money Q1 of 2028 unless they dilute. The growth is still good, considering they have no patch pump, but I’m not clear what’s going to happen when they burn through their stash.
1 · Reply
MarketBeat
MarketBeat May. 13 at 6:06 AM
https://marketbeat.com/a/8651341/ $BBNX Beta Bionics Touts Pharmacy Push, iLet Momentum and 2027 Mint Patch Pump Plans
0 · Reply
deepthinker
deepthinker May. 10 at 3:18 PM
$BBNX I would be surprised if we don’t get a bid given the crushed stock price here. Easy to consolidate and clean up the SG&A. Toss the iLet in another bag. Too many players in this space.
0 · Reply
deepthinker
deepthinker May. 7 at 1:45 PM
$BBNX My hunch is this company could be in play here. Tandem has supply and IP issues. DEKA is private. Minimed is still owned by Medtronic.
0 · Reply
ScoutWatch12
ScoutWatch12 May. 7 at 2:18 AM
$BBNX as a T1D using this pump - we aren’t wrong, just early. (It’s the same thing!! I know) patience. This is unbelievably ahead of tandem, omnipod, twist, and the unmentionables. They must figure out how to get the doctors onboard. The pump castrates the endocrinologist and they don’t like that at all.
2 · Reply
deepthinker
deepthinker May. 6 at 7:32 PM
$PODD Who’s likely not in play: Tandem, DEKA, MiniMed. Who’s in play: $BBNX
0 · Reply
deepthinker
deepthinker May. 6 at 7:01 PM
$BBNX Given Insulet’s slowing growth arc, they may look to buy growth.
0 · Reply
firewulf
firewulf May. 5 at 11:39 PM
$BBNX remember when the CFO sold 30 percent of his stock at $30. Love the comments defending this company though
0 · Reply
deepthinker
deepthinker May. 2 at 3:42 PM
$BBNX I don’t quite understand the strategy here. They’re going to try and build revenues even if it drains cash to zero in 7 quarters? What happens then? In my opinion, there are just too many companies in this space. It’s causing spend to get out of control. The first victim will be this company. They should reverse course and go for profitability rather than growth.
4 · Reply
BillionerOfKing
BillionerOfKing May. 2 at 2:30 AM
$BBNX Current Stock Price: $10.27 Contracts to trade: $10.0 BBNX May 15 2026 Call Entry: $0.55 Exit: $0.91 ROI: 66% Hold ~31 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
Arcides
Arcides Apr. 28 at 7:26 PM
$BBNX medical devices stocks are trash...
1 · Reply
firewulf
firewulf Apr. 27 at 4:58 PM
$BBNX 🙏
0 · Reply
PenkeInvesting
PenkeInvesting Apr. 25 at 8:11 PM
Fundamental analysis of $BBNX (Beta Bionics, Inc.) based on financial data and reported results. #BBNX
0 · Reply
jazzv
jazzv Apr. 24 at 2:04 AM
$BBNX possible cheap target for m&a
0 · Reply
firewulf
firewulf Apr. 22 at 3:36 PM
$BBNX 😂
0 · Reply
DARKP00L
DARKP00L Apr. 22 at 12:39 PM
$BBNX 08:31 on Apr. 22 2026 Stifel Maintains Buy on Beta Bionics, Lowers Price Target to $20 #tradeideas
0 · Reply